TARGETING TUMOR MICROENVIRONMENT-ASSOCIATED IMMUNE CELLS WITH NANOPARTICLES-BASED STRATEGIES

被引:2
|
作者
Alotaibi, Najla Suhail [1 ]
机构
[1] King Abdulaziz Univ, King Fahad Med Res Ctr, Immunol Unit, Jeddah, Saudi Arabia
来源
PHARMACOPHORE | 2021年 / 12卷 / 04期
关键词
Tumor microenvironment; Nanoparticles; Nanotechnology; Cancer; Immunotherapy; SUPPRESSOR-CELLS; DENDRITIC CELLS; MACROPHAGE POLARIZATION; CANCER; ACTIVATION; OLIGODEOXYNUCLEOTIDES; PROGRESSION; METASTASIS; INHIBITION; EXPRESSION;
D O I
10.51847/PJ1xCWaW3U
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The propensity of cancer cells to escape the immune system and to initiate a complex balance environment is due to its ability to utilize immune cells via associated factors, including non-tumoral components such as blood vessels, fibroblasts, cells, and signaling molecules. Collectively, these are referred to as the tumor microenvironment (TME). TME is the tumor's surrounding environment and has a crucial role in promoting tumor progression, angiogenesis, metastasis, and increasing tumor resistance to several therapies. TME's immunosuppressive factors depress the immune response after altering the metabolism of immune cells within TME. Accordingly, targeting TME with nanoparticles may be a beneficial tool to regulate and enhance the efficacy of tumor immunotherapies. Here, we review distinct structural and functional properties of immune cells within TME, tumor-associated immunosuppressive factors, and the interaction between TME and immune cells. We finish with a summary of recent findings related to novel nanoparticle strategies to target TME. Copyright (C) 2013 - All Rights Reserved -Pharmacophore
引用
收藏
页码:1 / 10
页数:10
相关论文
共 50 条
  • [1] Nanoparticles Targeting Innate Immune Cells in Tumor Microenvironment
    Jang, Hochung
    Kim, Eun Hye
    Chi, Sung-Gil
    Kim, Sun Hwa
    Yang, Yoosoo
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (18)
  • [2] Improving the efficacy of immunotherapy for colorectal cancer: Targeting tumor microenvironment-associated immunosuppressive cells
    Zou, Daoyang
    Xin, Xi
    Xu, Yunxian
    Xu, Huangzhen
    Huang, Linyan
    Xu, Tianwen
    HELIYON, 2024, 10 (16)
  • [3] Identifying the tumor immune microenvironment-associated prognostic genes for prostate cancer
    Shi Zong
    Ji Gao
    Discover Oncology, 15
  • [4] Identifying the tumor immune microenvironment-associated prognostic genes for prostate cancer
    Zong, Shi
    Gao, Ji
    DISCOVER ONCOLOGY, 2024, 15 (01)
  • [5] Prediction and therapeutic targeting of the tumor microenvironment-associated gene CTSK in gastric cancer
    Bai, Zilong
    Yan, Chunyu
    Chang, Dongmin
    DISCOVER ONCOLOGY, 2023, 14 (01)
  • [6] Prediction and therapeutic targeting of the tumor microenvironment-associated gene CTSK in gastric cancer
    Zilong Bai
    Chunyu Yan
    Dongmin Chang
    Discover Oncology, 14
  • [7] Tumor microenvironment-associated modifications of alternative splicing
    Brosseau, Jean-Philippe
    Lucier, Jean-Francois
    Nwilati, Hanad
    Thibault, Philippe
    Garneau, Daniel
    Gendron, Daniel
    Durand, Mathieu
    Couture, Sonia
    Lapointe, Elvy
    Prinos, Panagiotis
    Klinck, Roscoe
    Perreault, Jean-Pierre
    Chabot, Benoit
    Abou-Elela, Sherif
    RNA, 2014, 20 (02) : 189 - 201
  • [8] Tumor Microenvironment-Associated Immune-Related Genes for the Prognosis of Malignant Pleural Mesothelioma
    Xu, Xiaoling
    Cheng, Lei
    Fan, Yun
    Mao, Weimin
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [9] Therapeutic Targeting of Tumor Cells and Tumor Immune Microenvironment Vulnerabilities
    Kalyanaraman, Balaraman
    Cheng, Gang
    Hardy, Micael
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [10] Strategies targeting tumor immune and stromal microenvironment and their clinical relevance
    Hu, Mengying
    Huang, Leaf
    ADVANCED DRUG DELIVERY REVIEWS, 2022, 183